Navigation Links
Molecular Devices Announces ImageXpress Micro XL High-Content Screening System
Date:9/13/2011

SUNNYVALE, Calif., Sept. 13, 2011 /PRNewswire/ -- Molecular Devices, LLC., a leader in bioanalytical systems for drug discovery, life science research, and bioassay/test development, today announced the launch of the XL model of the ImageXpress® Micro System. Improving upon the existing ImageXpress Micro Widefield High-Content Screening System, the ImageXpress Micro XL System offers researchers the benefit of imaging twice the sample area to deliver statistically relevant results in half the time.

(Logo: http://photos.prnewswire.com/prnh/20100406/SF82092LOGO)

Incorporating state-of-the-art detector and illumination technologies, the system can capture cellular resolution images using a single-field that encompasses one 384 well, maximizing content up to 2-fold of what is acquired with standard camera HCS systems. This generous increase in field-of-view allows users to image twice the number of objects per image, minimizing the need to tile when capturing sizeable objects that span across the sample. The new MetaXpress® 4 Software complements the ImageXpress Micro XL System by increasing image analysis speed 100%, allowing acquisition and analysis of greater than 10 million cells per hour.

Maintaining the most extensive sample and objective compatibility, the ImageXpress Micro XL System raises the bar as the most flexible widefield high content screening system on the market. Combined with the longevity of a 10,000+ hour light source, researchers can feel confident in system robustness, while gaining a greater peace-of-mind the instrument will grow with their expanding applications.

"The launch of the ImageXpress Micro XL System is a shining example of Molecular Devices' ability to support researchers' efforts to run more screens and perform hit selection faster. Whether you are searching for rare events or investigating multifaceted cell signaling pathways, we are excited to offer twice the data points per image to decrease your time to perform cellular- and high-resolution screens" said Jennifer McKie, Senior Marketing Director, BioImaging at Molecular Devices.

"Assay window and reliability are enhanced with 3-log dynamic range and <5% CV for intensities across the plate, making certain your scientific breakthroughs are picture perfect for research publications" stated Jennifer McKie. "We believe these enhancements ensure researchers are equipped with the latest high content imaging technology to be at the forefront of drug discovery and cellular research."

The ImageXpress Micro XL System will be showcased at the MipTec, September 20 – 22 2011, Basel, Switzerland (Booth D33). For more information regarding the ImageXpress Micro XL System, go to http://www.HighThroughputImaging.com/screening/

About Molecular Devices, LLC.

At Molecular Devices we have one focus—our customers. Whether a long-time user, recent adopter, or prospective customer, your needs fuel our actions. We hire creative, best-in-class people to design, manufacture, and commercialize analytical instruments, software, and assays as well as provide dedicated follow-on support. Understanding your laboratory workflow is our top priority, and we direct product development toward solving your unique issues. Our instruments offer a full spectrum of detection technologies and meet all throughput needs—from dedicated, single-readout devices to multi-readout systems. Our goal is to deliver highly relevant analytical products to detect biology, decode data, and drive discovery. With headquarters in Silicon Valley and offices around the globe, we support and enrich efforts of the international BioResearch, BioPharma, and BioTesting communities. Visit us today at www.MolecularDevices.com.

Molecular Devices products are for Research Use Only. Not for use in diagnostic procedures.

The trademarks mentioned herein are the property of Molecular Devices, LLC., or their respective owners.

© 2011. Molecular Devices, LLC.


'/>"/>
SOURCE Molecular Devices, LLC.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Molecular Devices Releases Breakthrough TUNE Technology, Now Part of the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform
2. Pathologists Gather to Focus on Advances in Molecular Testing, Digital Imaging, and Biospecimens
3. International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment
4. Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicines Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds
5. Molecular Devices Continues to Lead the Way in Quality Control and Validation Compliance With a New ISO/IEC 17025 Accreditation
6. New Research Demonstrates High Prevalence of Sexually Transmitted Disease Trichomonas Vaginalis and Potential of New Molecular Test to Improve Detection
7. Genetix Joins Molecular Devices: Combining Businesses to be in a Better Position to Serve Customers
8. Amsterdam Molecular Therapeutics Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients
9. Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
10. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
11. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):